ALX Oncology Holdings (ALXO) Gets a Buy from Jefferies

Tip Ranks
2025.11.13 13:57
portai
I'm PortAI, I can summarize articles.

Jefferies analyst initiated coverage with a Buy rating on ALX Oncology Holdings, setting a price target of $4.00. H.C. Wainwright also issued a Buy rating, while LifeSci Capital maintained a Hold rating. The news highlights differing analyst opinions on ALX Oncology Holdings.

Jefferies analyst initiated coverage with a Buy rating on ALX Oncology Holdings today and set a price target of $4.00.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

In addition to Jefferies, ALX Oncology Holdings also received a Buy from H.C. Wainwright’s Swayampakula Ramakanth in a report issued on November 10. However, on November 9, LifeSci Capital maintained a Hold rating on ALX Oncology Holdings (NASDAQ: ALXO).

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer